personalised healthcare

As the first calls are launched and the details revealed, Science|Business examines the Horizon 2020 draft programmes. Here is the programme for Health, demographic change and well-being

Invalidating two biomarker patents could hold back the commercial development of personalized medicine

The $1,000 genome has arrived, providing the spur for personalised healthcare to move from theory to practice. Some existing examples of best practice and roadmaps for the future are pointing the way

Personalised healthcare promises long-term value. But how can Europe justify the upfront costs at a time of massive cuts in public spending?

A new study finds that investment in computer, communications and diagnostics technologies could drastically cut the long-term care costs for breast cancer and cardiovascular disease, through better use of patient screening and adherence to treatment.

Multi-million pound awards to boost research and enable the development of more effective medicines, treatments and care for patients

Six new collaborative projects have been funded by the UK Technology Strategy Board to advance personalised medicine in cancer and lay foundations for national adoption